The Top 5 VC deals of the first half of 2007

Venture capital is the lifeblood of up-and-coming biotechs. In order to interest investors and keep the money coming in, biotechs must have a strong vision, promising pipeline and a management team that can guide a company through the rigorous drug development process. For a look at which biotechs have gained the most attention this year, check out the five promising companies that raised the most money in the first half of 2007.

Ception Therapeutics

Targanta Therapeutics

  Portola Pharmaceuticals

Novexel

Movetis